GlassScriptPhysician profile
Thomas T Hoang
NPI 1124222799
$2,481.23
in general payments reported to CMS, 2019-2025
29 companies · $840 in 2025
The $840 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2020: $87.06 · 2021: $67.47 · 2022: $587 · 2023: $192 · 2024: $380 · 2025: $840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,411.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $358.21 | 2019-2025 | Axonics, Spaceoar Vue System - 10ml |
| Abbvie INC. | $345.74 | 2019-2025 | |
| Abc Home Medical Supply, INC. | $255.11 | 2022-2024 | |
| Urogen Pharma, INC. | $217.51 | 2023-2025 | Jelmyto |
| Astellas Pharma US INC | $198.16 | 2019-2025 | Xtandi |
| Ferring Pharmaceuticals INC. | $155.01 | 2025 | Adstiladrin |
| Janssen Biotech, INC. | $115.55 | 2022-2025 | Erleada, Rybrevant, Carvykti |
| Merck Sharp & Dohme LLC | $107.86 | 2025 | Keytruda |
| Ambu INC. | $91.61 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $78.12 | 2022-2024 | |
| Bluewind Medical | $62.18 | 2025 | Revi |
| Laborie Medical Technologies Corp. | $59.21 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Biotissue Holdings INC. | $52.05 | 2022-2024 | |
| Myovant Sciences INC. | $38.52 | 2022 | |
| Antares Pharma, INC. | $35.09 | 2024 | Xyosted |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $31.34 | 2023 | Bard Urinary Drainage Bag |
| Tolmar, INC. | $27.86 | 2025 | Jatenzo, Eligard |
| Procept Biorobotics Corporation | $24.67 | 2022 | |
| Progenics Pharmaceuticals, INC. | $24.17 | 2022 | |
| Accord Healthcare, INC. | $23.24 | 2024 | |
| Edap Technomed INC | $23.00 | 2022 | |
| Endo Pharmaceuticals INC. | $22.76 | 2024 | Xiaflex |
| Olympus America INC. | $22.53 | 2021 | |
| Sumitomo Pharma America, INC. | $22.05 | 2025 | Gemtesa |
| Alafair Biosciences, INC. | $21.73 | 2022 | |
| Davol INC. | $21.61 | 2023 | Arista Ah Flexitip |
| Teleflex LLC | $17.90 | 2024 | Urolift |
| Integra Lifesciences Corporation | $15.06 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Allergan, INC. | $13.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Hoang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.